Metformin Extended-Release Tablets (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Hyple Life Sciences Co., Ltd.
MFDS item code 201906869 · Approved 2019.09.26
This product's status changed to Approval withdrawn on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of type 2 diabetes mellitus in adults whose blood glucose is inadequately controlled by diet and exercise
This medication is used primarily for adults with Type 2 diabetes whose blood sugar control is not sufficiently managed by diet and exercise alone. It is especially effective in overweight diabetic patients and can be used alone or in combination with other oral hypoglycemic agents or insulin. This helps effectively control blood sugar levels, aiding in diabetes management.
The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. The usual starting dose is one 500mg extended-release metformin hydrochloride tablet once daily with the evening meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. When increasing the dose, increase by 500mg each week; up to a maximum of 2000mg per day may be taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. For patients already being treated with metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking 2000mg or more per day of immediate-release metformin tablets. At treatment initiation and during dose adjustment, fasting blood glucose should be measured to assess the response to this medicine and determine the minimum effective dose. Blood glycated hemoglobin levels should be measured approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be closely monitored every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine should be discontinued immediately.
This medication can rarely cause a serious metabolic complication called lactic acidosis, which can result in death. Caution should be taken as hypoglycemic symptoms may occur when used together with other diabetes medications. It should not be administered to patients with moderate to severe impaired renal function or those with acute conditions such as dehydration, severe infections, or heart failure. If undergoing tests involving iodine-based contrast agents, this medication should be temporarily discontinued before and after the examination, and it should be resumed only after ensuring normal kidney function. It is contraindicated in patients with a history of allergic reactions to this medication, those with Type 1 diabetes, or those with ketoacidosis. Patients with severe infections or scheduled surgeries should also temporarily discontinue this medication, and it can be resumed once the condition improves. It is also advisable not to use this medication if nutritional status is poor, or in cases of liver dysfunction, excessive alcohol consumption, severe dehydration, vomiting, or significant diarrhea. As this medication is excreted through the kidneys, regular kidney function tests should be done before and during treatment, and if renal function declines rapidly, use should be stopped. Blood glucose control should be monitored periodically during treatment, and hypoglycemic symptoms may occur, especially when used in conjunction with other hypoglycemic agents. Alcohol can increase the risk of side effects, so it is best to avoid drinking while taking this medication. During pregnancy, this medication can affect the fetus, so consultation with a doctor is essential if planning to become pregnant or if already pregnant. In breastfeeding mothers, this medication may pass into breast milk and affect the infant, so consultation with a healthcare professional regarding breastfeeding and medication use is necessary. Elderly patients are at higher risk for reduced kidney function, making dosage adjustment and monitoring of kidney function important. In case of overdose, the risk of lactic acidosis is greater than that of hypoglycemia, so if suspected, immediate medical attention should be sought for appropriate treatment. This medication should be swallowed whole and not chewed or crushed, and while its outer shell may appear in stool, this is a normal occurrence. Regular blood tests and kidney function tests during the course of this medication are important to ensure safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is best to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will prolong the effectiveness of the medication.
White, double convex, rectangular extended-release tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Hyple Life Sciences Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.